Fig. 1From: ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cellsHigh ARHGEF15 expression levels in pancreatic cancers are associated with a poor prognosis. a A heatmap of differentially expressed genes was determined by Affymetrix X3P GeneChip microarray analysis in specimens obtained from 39 PDAC patients. The top five most differentially expressed genes between the poor prognosis and better prognosis groups are listed. b Kaplan-Meier estimates of the relationships between the expression levels of ARHGEF15, SEPT6 and MATR3 in the tumors by separate real-time RT-PCR analyses and the prognosis of the PDAC patientsBack to article page